|Other Names||Tykerb, Lapatinib Ditosylate, GW572016, 231277-92-2, GW 572016, Tycerb, 1xkk, Lapatinib (INN), Lapatinib [INN]|
|Treatment By||Pill - Oral|
|Tumor Target||Vestibular Schwannoma|
|Inhibitor||dual TKI Antineoplastic Agent - Tyrosine Kinase Inhibitor, interrupts the HER2/neu and Epidermal Growth Factor Receptor (EGFR) pathways|
Breast cancer and others.
Major side effects are uncommon. Since people with NF2 are taking these medications at a low dose, only minimal side effects are common. However, long term use is primarily where these major side effects take place. Monthly Blood and Urine Tests can usually point to an issue before it's a real problem. Talk to your doctor.
Liver Damage: Look for dark urine, feeling tired, not hungry, nausea, vomiting or yellowing of skin and/or eyes.
Take Lapatinib at night instead of the morning to prevent fatigue.
Disclaimer: Neurofibromatosis Type 2 - Information and Services, www.nf2is.org, is not run by medical experts, affiliated with
any healthcare organization or any other company. No assurance can be made to the accuracy or completeness of the information provided here,
the accuracy of other sites to which this site links, or of sites that link to this site. - Read More
Copyright © 2008 - 2017